Ubs Asset Management Americas Inc Jazz Pharmaceuticals PLC Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 174,078 shares of JAZZ stock, worth $21.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

174,078

Previous 73,966 135.35%

Holding current value

$21.5 Million

Previous $7.89 Million 145.78%

% of portfolio

0.01%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.57 - $116.37 $10.1 Million - $11.7 Million	100,112 Added 135.35%	174,078 $19.4 Million
Q2 2024 Aug 13, 2024	SELL	$103.94 - $118.98 $17.4 Million - $20 Million	-167,719 Reduced 69.4%	73,966 $7.89 Million
Q1 2024 May 15, 2024	BUY	$115.19 - $132.77 $1.01 Million - $1.17 Million	8,805 Added 3.78%	241,685 $29.1 Million
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $478,977 - $570,112	-4,192 Reduced 1.77%	232,880 $28.6 Million
Q3 2023 Nov 13, 2023	SELL	$122.0 - $145.31 $7.3 Million - $8.69 Million	-59,825 Reduced 20.15%	237,072 $30.7 Million
Q1 2023 May 15, 2023	SELL	$133.98 - $160.47 $713,309 - $854,342	-5,324 Reduced 1.76%	296,897 $43.4 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $1.71 Million - $2.11 Million	13,204 Added 4.57%	302,221 $48.1 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $14,304 - $18,213	-113 Reduced 0.04%	289,017 $38.5 Million
Q2 2022 Aug 12, 2022	SELL	$141.59 - $168.66 $5.5 Million - $6.56 Million	-38,876 Reduced 11.85%	289,130 $45.1 Million
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $30.2 Million - $37.4 Million	-232,935 Reduced 41.53%	328,006 $51.1 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $26.9 Million - $32.6 Million	224,125 Added 66.54%	560,941 $71.5 Million
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $3.31 Million - $4.75 Million	-25,703 Reduced 7.09%	336,816 $43.9 Million
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $1.49 Million - $1.73 Million	9,306 Added 2.63%	362,519 $64.4 Million
Q1 2021 May 14, 2021	SELL	$150.19 - $173.5 $5.92 Million - $6.84 Million	-39,435 Reduced 10.04%	353,213 $58.1 Million
Q4 2020 Mar 01, 2021	BUY	$140.71 - $165.05 $1.61 Million - $1.89 Million	11,449 Added 3.0%	392,648 $64.8 Million
Q3 2020 Nov 13, 2020	SELL	$105.46 - $144.13 $3,058 - $4,179	-29 Reduced 0.01%	381,199 $54.4 Million
Q2 2020 Aug 14, 2020	SELL	$95.68 - $121.88 $2.31 Million - $2.95 Million	-24,175 Reduced 5.96%	381,228 $42.1 Million
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $651,908 - $1.13 Million	-7,430 Reduced 1.8%	405,403 $40.4 Million
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $8.46 Million - $11.1 Million	71,942 Added 21.1%	412,833 $61.6 Million
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $2.29 Million - $2.62 Million	-18,271 Reduced 5.09%	340,891 $43.7 Million
Q2 2019 Aug 15, 2019	BUY	$125.55 - $144.48 $311,740 - $358,743	2,483 Added 0.7%	359,162 $0
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $10.1 Million - $11.8 Million	82,657 Added 30.16%	356,679 $0
Q4 2018 Feb 13, 2019	SELL	$115.94 - $166.74 $684,509 - $984,432	-5,904 Reduced 2.11%	274,022 $34 Million
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $2.1 Million - $2.36 Million	13,061 Added 4.89%	279,926 $0
Q2 2018 Aug 14, 2018	BUY	$146.33 - $183.18 $5.79 Million - $7.25 Million	39,581 Added 17.41%	266,865 $0
Q1 2018 May 14, 2018	BUY	$135.59 - $157.16 $4.81 Million - $5.58 Million	35,511 Added 18.52%	227,284 $0
Q4 2017 Feb 09, 2018	BUY	$131.06 - $150.39 $2.06 Million - $2.37 Million	15,739 Added 8.94%	191,773 $0
Q3 2017 Nov 13, 2017	BUY	$142.62 - $155.6 $25.1 Million - $27.4 Million	176,034	176,034 $0

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.76B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Jazz Pharmaceuticals PLC Transaction History